Yanxia Liu

5.5k total citations · 1 hit paper
35 papers, 3.7k citations indexed

About

Yanxia Liu is a scholar working on Molecular Biology, Aging and Plant Science. According to data from OpenAlex, Yanxia Liu has authored 35 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 5 papers in Aging and 4 papers in Plant Science. Recurrent topics in Yanxia Liu's work include CRISPR and Genetic Engineering (15 papers), Pluripotent Stem Cells Research (9 papers) and Genetics, Aging, and Longevity in Model Organisms (5 papers). Yanxia Liu is often cited by papers focused on CRISPR and Genetic Engineering (15 papers), Pluripotent Stem Cells Research (9 papers) and Genetics, Aging, and Longevity in Model Organisms (5 papers). Yanxia Liu collaborates with scholars based in United States, China and Hong Kong. Yanxia Liu's co-authors include Lei S. Qi, Marie La Russa, Qin Han, Mingxiao Ding, Yang Zhao, Hongkui Deng, Zhihua Song, Jun Cai, Gary Ruvkun and Xueqiu Lin and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

Yanxia Liu

35 papers receiving 3.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza

2020 371 citations Timothy R. Abbott, Girija Dhamdhere et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yanxia Liu United States	24	2.9k	520	460	418	371	35	3.7k
Elena Miranda Italy	29	2.1k 0.7×	302 0.6×	72 0.2×	213 0.5×	184 0.5×	84	3.8k
M. Inmaculada Barrasa United States	27	2.5k 0.9×	84 0.2×	352 0.8×	169 0.4×	74 0.2×	45	3.7k
Mo R. Ebrahimkhani United States	30	1.5k 0.5×	309 0.6×	61 0.1×	427 1.0×	438 1.2×	54	2.6k
Nahid F. Mivechi United States	35	3.0k 1.0×	99 0.2×	327 0.7×	77 0.2×	268 0.7×	90	3.8k
Jianping Zhang China	28	3.0k 1.0×	245 0.5×	89 0.2×	154 0.4×	83 0.2×	63	3.7k
Arjun Bhutkar United States	32	3.6k 1.2×	214 0.4×	96 0.2×	26 0.1×	169 0.5×	55	5.6k
Raúl Méndez Spain	38	4.9k 1.7×	266 0.5×	102 0.2×	400 1.0×	27 0.1×	71	6.1k
Yoav D. Shaul Israel	23	3.2k 1.1×	291 0.6×	92 0.2×	42 0.1×	78 0.2×	40	4.6k
Sandra Lacas‐Gervais France	32	2.7k 0.9×	680 1.3×	71 0.2×	61 0.1×	59 0.2×	63	4.5k
Christoph Reinhard United States	20	3.6k 1.3×	182 0.3×	105 0.2×	47 0.1×	95 0.3×	35	4.7k

Countries citing papers authored by Yanxia Liu

Since Specialization

Citations

This map shows the geographic impact of Yanxia Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanxia Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanxia Liu more than expected).

Fields of papers citing papers by Yanxia Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanxia Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanxia Liu. The network helps show where Yanxia Liu may publish in the future.

Co-authorship network of co-authors of Yanxia Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanxia Liu. A scholar is included among the top collaborators of Yanxia Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanxia Liu. Yanxia Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Zhenglong, Xingyu Ding, Yong Gao, et al.. (2025). In-situ X-ray absorption spectroscopy in hydrogen evolution reaction: Insights and applications. Materials Science and Engineering R Reports. 166. 101061–101061. 1 indexed citations

Liu, Chun, Mengcheng Shen, Wilson Lek Wen Tan, et al.. (2023). Statins improve endothelial function via suppression of epigenetic-driven EndMT. Nature Cardiovascular Research. 2(5). 467–485. 49 indexed citations

Lin, Xueqiu, Yanxia Liu, Shuai Liu, et al.. (2022). Nested epistasis enhancer networks for robust genome regulation. Science. 377(6610). 1077–1085. 61 indexed citations

Lin, Xueqiu, et al.. (2021). A comprehensive analysis and resource to use CRISPR-Cas13 for broad-spectrum targeting of RNA viruses. Cell Reports Medicine. 2(4). 100245–100245. 30 indexed citations

Liu, Yanling, Fengjiao Huang, Jiao Wang, et al.. (2021). Long noncoding RNA MIR22HG promotes Leydig cell apoptosis by acting as a competing endogenous RNA for microRNA-125a-5p that targets N-Myc downstream-regulated gene 2 in late-onset hypogonadism. Laboratory Investigation. 101(11). 1484–1493. 9 indexed citations

Liu, Yanling, Yanxia Liu, Jiao Wang, et al.. (2021). LncRNA FENDRR promotes apoptosis of Leydig cells in late-onset hypogonadism by facilitating the degradation of Nrf2. Cell and Tissue Research. 386(2). 379–389. 6 indexed citations

Liu, Yanxia, et al.. (2020). A novel compound heterozygous mutation in the arginase-1 gene identified in a Chinese patient with argininemia. Medicine. 99(32). e21634–e21634. 6 indexed citations

Abbott, Timothy R., Girija Dhamdhere, Yanxia Liu, et al.. (2020). Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza. Cell. 181(4). 865–876.e12. 371 indexed citations breakdown →

Wang, Haifeng, Muneaki Nakamura, Timothy R. Abbott, et al.. (2019). CRISPR-mediated live imaging of genome editing and transcription. Science. 365(6459). 1301–1305. 219 indexed citations

10.

Liu, Peng, Meng Chen, Yanxia Liu, Lei S. Qi, & Sheng Ding. (2018). CRISPR-Based Chromatin Remodeling of the Endogenous Oct4 or Sox2 Locus Enables Reprogramming to Pluripotency. Cell stem cell. 22(2). 252–261.e4. 119 indexed citations

11.

Liu, Yanxia, Yu Chen, Timothy Daley, et al.. (2018). CRISPR Activation Screens Systematically Identify Factors that Drive Neuronal Fate and Reprogramming. Cell stem cell. 23(5). 758–771.e8. 150 indexed citations

12.

Wang, Haifeng, Xiaoshu Xu, Cindy M. Nguyen, et al.. (2018). CRISPR-Mediated Programmable 3D Genome Positioning and Nuclear Organization. Cell. 175(5). 1405–1417.e14. 156 indexed citations

13.

Zhāng, Qí, Man Shang, Mengxiao Zhang, et al.. (2016). Microvesicles derived from hypoxia/reoxygenation-treated human umbilical vein endothelial cells promote apoptosis and oxidative stress in H9c2 cardiomyocytes. BMC Cell Biology. 17(1). 25–25. 49 indexed citations

14.

Chen, Yu, Yanxia Liu, Tianhua Ma, et al.. (2015). Small Molecules Enhance CRISPR Genome Editing in Pluripotent Stem Cells. Cell stem cell. 16(2). 142–147. 329 indexed citations

15.

Liu, Yanxia, et al.. (2015). Transcription Factor Competition Allows Embryonic Stem Cells to Distinguish Authentic Signals from Noise. Cell Systems. 1(2). 117–129. 60 indexed citations

16.

Liu, Yanxia. (2010). Culture and identification of endothelial cells from calf thoracic aorta in vitro. 2 indexed citations

17.

Song, Zhihua, Jun Cai, Yanxia Liu, et al.. (2009). Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Research. 19(11). 1233–1242. 369 indexed citations

18.

Liu, Yanxia, Brian K. Law, & Hendrik Luesch. (2009). Apratoxin A Reversibly Inhibits the Secretory Pathway by Preventing Cotranslational Translocation. Molecular Pharmacology. 76(1). 91–104. 112 indexed citations

19.

Han, Qin, Tianxin Yu, Tingting Qing, et al.. (2006). Regulation of Apoptosis and Differentiation by p53 in Human Embryonic Stem Cells. Journal of Biological Chemistry. 282(8). 5842–5852. 207 indexed citations

20.

Liu, Yanxia, Zhihua Song, Yang Zhao, et al.. (2006). A novel chemical-defined medium with bFGF and N2B27 supplements supports undifferentiated growth in human embryonic stem cells. Biochemical and Biophysical Research Communications. 346(1). 131–139. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact